Cardiovascular diseases (CVDs) are related to heart and blood vessel disorders. The changing lifestyles of unhealthy diets, physical inactivity, and tobacco and alcohol consumption have increased the risk factors of heart diseases. A literature search reveals that the rise in risk of CVD's is higher after a SARS-COV2 infection. Also, CVDs independently are one of the leading cause of death globally. There is hence a need of research of new molecules with improved therapeutics. Herbal medications have been utilized to treat cardiovascular diseases for many years around the world. The advancement of herbal nanotechnology in the field of CVDs has been shown to have astounding benefits over herbal crude drug formulations or herbal extracts, including better solubility, bioavailability, toxicity protection, pharmacological activity augmentation, dose reduction, and stability. This paper discusses the traditional herbal drugs and the herbal formulations, specifically herbal nanoparticles (NPs), for the treatment of CVDs and their advantages.
INTRODUCTION:CVDs are the biggest cause of death worldwide and are expected to continue to be so. Coronavirus disease 2019 (COVID-19), caused by a coronavirus strain known as SARS-CoV-2, has spread worldwide, affecting billions of people. COVID-19 and cardiovascular disease appear to be linked, according to research. Patients with COVID-19 with pre-existing cardiovascular illness had the worst results and were more likely to die, whereas COVID-19 can also cause myocardial damage, arrhythmia, acute coronary syndrome, and venous thromboembolism, which has become a severe concern 1 .